As of the end of 2023, nearly 40 million people worldwide were living with HIV, including approximately 1.2 million in the ...

The number of people living with HIV in South Africa has reached the eight million mark for the first time. About 6.2 million ...

Babies born to HIV-positive mothers in Kenya face an increased risk of contracting the virus due to a shortage of critical ...

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

The global AIDS response has seen substantial reductions in HIV incidence and number of deaths.1 The greatest improvements have been recorded in sub-Saharan Africa, the region with the worst HIV ...

Although progress towards the UN's targets to end AIDS as a public health threat by 2030 has been impressive, with an estimated 14 million lives saved since 2010 thanks to antiretroviral therapy (ART) ...

A new modeling study published in The Lancet HIV journal highlights the alarming potential impact of significant reductions ...

Acute retroviral syndrome (ARS) is the collection of HIV signs and symptoms that occur during acute HIV infection (AHI) when the immune system mounts a defense against the virus as it first enters the ...

Study findings provide a new gene pathway for potential treatment of the virus affecting millions. Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the ...

HIV symptoms vary by the stage of infection, known as acute HIV infection (Stage 1), chronic HIV infection (Stage 2), and AIDS (Stage 3). During primary infection, the symptoms are caused by the virus ...

Human immunodeficiency virus, or HIV, is a virus that attacks the body’s immune system and it can lead to acquired immunodeficiency syndrome (AIDS). Currently, while there is no cure for HIV ...

Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months.